Abstract
Apoptosis is an essential physiological process that regulates cellular proliferation. Here, we explored the effect of DNA sequence variation within the BCL-2 gene on prostate cancer susceptibility in three clinical populations, consisting of 428 African Americans, 214 Jamaicans and 218 European Americans. We observed a 70% reduced risk for prostate cancer among the European Americans who had possessed two copies of a promoter variant -938C/A. Additionally, common BCL-2 haplotypes appeared to influence prostate cancer risk; however, studies in larger data sets are needed to confirm our findings. Our data suggest that inherited BCL-2 variants may be associated with a decrease in prostate cancer susceptibility.
Original language | English (US) |
---|---|
Pages (from-to) | 284-292 |
Number of pages | 9 |
Journal | Prostate Cancer and Prostatic Diseases |
Volume | 9 |
Issue number | 3 |
DOIs | |
State | Published - Sep 2006 |
Keywords
- Apoptosis
- Bcl-2
- Prostate cancer
ASJC Scopus subject areas
- Oncology
- Urology
- Cancer Research